Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep1145 | Thyroid | ECE2022

Thyroid ultrasound characteristics in malignancy prediction

Velkoska Nakova Valentina

Objective: To evaluate the diagnostic accuracy of thyroid ultrasound characteristics of nodules in prediction of malignancy.Material and methods: Retrospectively were analyzed 102 patients who underwent for FNA biopsy of thyroid nodule. All patients were examined by one ultrasound examiner. Size, taller than wide, echogenicity, borders, halo, calcification, and internal vascularity were recorded in all examined nodules. The Bethesda System for Reporting ...

ea0081p225 | Thyroid | ECE2022

Comparison in lipid parameters before and after L-thyroxine treatment in subclinical hypothyroidism according to the presence of thyroid peroxidase antibodies

Velkoska Nakova Valentina , Krstevska Brankica , Cheshlaroska Markushoska Katerina , Jovanovska Mishevska Sasha , Milenkovic Tatjana

Objective: Subclinical hypothyroidism (ScH) is a common condition and may be associated with dyslipidemia. We investigated the effect of levothyroxine therapy (L-T4) on lipid parameters in patients with a mild form of subclinical hypothyroidism according to the presence of thyroid peroxidase antibodies (anti-TPO antibodies). Material and methods: Fifty-seven patients with newly diagnosed ScH (TSH levels between upper reference value and 10 mIU/l with nor...

ea0070ep518 | Thyroid | ECE2020

Management of subclinical hyperthyroidism presented by several cases

Velkoska Nakova Valentina , Krstevska Brankica , Pemovska Gordana , Ahmeti Irfan , Milenkovic Tatjana

Subclinical hyperthyroidism (ScHyper) is a condition with suppressed TSH, and normal free T3 and free T4 hormones, affecting 10% of the population. There are two subgroups of patients, the first group with TSH lower than 0.1 U/l, and the second group with mildly suppressed TSH between 0.1 and the lower assay reference limit. The patients from the first group should be treated, but there is no evidence for therapy for the second group of patients.We prese...